Advertisement
Screener

Rosetta Genomics Ltd. Assets, Fair Value Disclosure

Rosetta Genomics Ltd. Assets, Fair Value Disclosure

Rosetta Genomics Ltd. had Assets, Fair Value Disclosure of $359.00 thousand as of 2012-12-31, per its 20-F filed 2013-03-22.

Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis › Fair Value, Net Asset (Liability)

us-gaap:AssetsFairValueDisclosure · last filed 2013-03-22

  • 2012-12-31: Assets, Fair Value Disclosure $359.00K.
Period endAssets, Fair Value Disclosure
2012-12-31$359.00K
20-F · filed 2013-03-22